Lakefront Biotherapeutics NV LKFT
Set alert
At close · Oct 30
After hours · Oct 30, 4:00 PM ET
- YTD
- -1.28%
- 1 year
- +3.00%
- Open
- 32.42
- Prev close
- 32.33
- Mkt cap
- 2.13B
- Vol
- 164.06K
- Avg vol
- 285.76K
- EPS
- 10.52
- P/E
- 3.07
- Div yield
- 0.00%
More statistics
- Low
- 32.06
- High
- 32.76
- Forward P/E
- -27.11
- Beta
- 0.06
- Short ratio
- 3.95
- Inst. own
- 23.68%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 11, 2026
- 50-d avg
- 29.41
- 200-d avg
- 29.93
- 1y target
- 30.34
News
1 week ago defenseworld.net
Oncocyte (NASDAQ:IMDX) and Lakefront Biotherapeutics American Depositary Shares (NASDAQ:LKFT) Head-To-Head Analysis
Oncocyte (NASDAQ: IMDX - Get Free Report) and Lakefront Biotherapeutics American Depositary Shares (NASDAQ: LKFT - Get Free Report) are both healthcare companies, but which is the superior business?…
1 week ago zacks.com
Lakefront Biotherapeutics - Sponsored ADR (LKFT) Upgraded to Buy: What Does It Mean for the Stock?
Lakefront Biotherapeutics - Sponsored ADR (LKFT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in…
2 weeks ago globenewswire.com
Lakefront Announces Sale of Preclinical CAR-T Programs to Armed Cell Therapeutics
Previously announced wind-down of the legacy cell therapy activities is substantially complete Mechelen, Belgium; October 14, 2026, 22.01 CEST; Lakefront Biotherapeutics NV (Euronext & NASDAQ: LKFT)…
2 weeks ago globenewswire.com
Acquisition of Own Shares
Mechelen, Belgium; October 13, 2026, 22.01 CET; regulated information Within the framework of the repurchase program announced on June 9, 2026, Lakefront Biotherapeutics NV (Euronext & NASDAQ: LKFT)…
-
3 weeks ago benzinga.com
Bank Of America Crosses Below Threshold Of 10% Of Lakefront's Voting Rights, Transparency Notification Shows
Pursuant to Belgian transparency legislation1, Lakefront received a transparency notification, from Bank of America Corporation on October 6, 2026. The notification indicates that Bank of America…
3 weeks ago globenewswire.com
Acquisition of Own Shares
Mechelen, Belgium; October 06, 2026, 22.01 CET; regulated information Within the framework of the repurchase program announced on June 9, 2026, Lakefront Biotherapeutics NV (Euronext & NASDAQ: LKFT)…
1 month ago globenewswire.com
Acquisition of Own Shares
Mechelen, Belgium; 29 September 2026, 22.01 CET; regulated information Within the framework of the repurchase program announced on June 9, 2026, Lakefront Biotherapeutics NV (Euronext & NASDAQ: LKFT)…
1 month ago benzinga.com
This 3M Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Friday
Analysts upgraded First Financial, 3M, Synopsys, Humana and Stem, raising targets for four while maintaining Stem’s $7 target.
1 month ago benzinga.com
Crude Oil Gains 1%; Cintas Earnings Top Views
U.S. stocks fell Wednesday, led by a 1.1% Nasdaq drop. Cintas beat estimates and raised guidance; oil gained while gold, silver and copper declined.
1 month ago benzinga.com
TriSalus Life Sciences, Lakefront Biotherapeutics, Editas Medicine And Other Big Stocks Moving Higher On Wednesday
U.S. stocks fell as Nasdaq dropped 100+ points, while TriSalus surged 5.8% on FDA clearance; Securitize, Lakefront and others also gained.
-
1 month ago benzinga.com
This Editas Medicine Analyst Turns Bullish; Here Are Top 4 Upgrades For Wednesday
Analysts upgraded Microsoft, Graphic Packaging, Editas Medicine and Lakefront Biotherapeutics, with mixed price-target changes.
-
1 month ago benzinga.com
RBC Capital Upgrades Lakefront Biotherapeutics to Outperform, Raises Price Target to $45
RBC Capital analyst Brian Abrahams upgrades Lakefront Biotherapeutics (NASDAQ:LKFT) from Sector Perform to Outperform and raises the price target from $26 to $45.
1 month ago globenewswire.com
Acquisition of Own Shares
Mechelen, Belgium; September 22, 2026, 22.01 CET; regulated information Within the framework of the repurchase program announced on June 9, 2026, Lakefront Biotherapeutics NV (Euronext & NASDAQ:…
1 month ago defenseworld.net
Lakefront Biotherapeutics Targets 2027 Registrational Trials for Gamgertamig
Lakefront Biotherapeutics American Depositary Shares (NASDAQ: LKFT) said it plans to begin registrational studies next year for its lead T-cell engager, gamgertamig, following a broad restructuring…
1 month ago marketbeat.com
Lakefront Biotherapeutics Targets 2027 Registrational Trials for Gamgertamig
Lakefront Biotherapeutics American Depositary Shares NASDAQ: LKFT said it plans to begin registrational studies next year for its lead T-cell engager, gamgertamig, following a broad restructuring of…
1 month ago seekingalpha.com
Lakefront Biotherapeutics NV (LKFT) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Lakefront Biotherapeutics NV (LKFT) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
1 month ago globenewswire.com
Acquisition of Own Shares
Mechelen, Belgium; 15 September 2026, 22.01 CET; regulated information Within the framework of the repurchase program announced on June 9, 2026, Lakefront Biotherapeutics NV (Euronext & NASDAQ: LKFT)…
1 month ago seekingalpha.com
Lakefront Biotherapeutics: A Cash Discount With A More Credible Path To Value
Lakefront Biotherapeutics offers valuation support and clinical upside, leveraging a new development model post-Ouro acquisition and partnership with Gilead. LKFT's €2.24 billion liquidity and…
1 month ago globenewswire.com
Acquisition of Own Shares
Mechelen, Belgium; 08 September 2026, 22.01 CET; regulated information Within the framework of the repurchase program announced on June 9, 2026, Lakefront Biotherapeutics NV (Euronext & NASDAQ: LKFT)…
1 month ago globenewswire.com
Lakefront to Present at the Morgan Stanley 24th Annual Global Healthcare Conference
Mechelen, Belgium; 8 September 2026, 22.01 CET; Lakefront Biotherapeutics NV (Euronext & NASDAQ: LKFT) today announced that the Company will host a fireside chat at the Morgan Stanley 24th Annual…
2 months ago globenewswire.com
Acquisition of Own Shares
Mechelen, Belgium; 01 September 2026, 22.01 CET; regulated information Within the framework of the repurchase program announced on June 9, 2026, Lakefront Biotherapeutics NV (Euronext & NASDAQ: LKFT)…
2 months ago globenewswire.com
Acquisition of Own Shares
Mechelen, Belgium; 25 August 2026, 22.01 CET; regulated information Within the framework of the repurchase program announced on June 9, 2026, Lakefront Biotherapeutics NV (Euronext & NASDAQ: LKFT)…
-
2 months ago benzinga.com
Bank Of America Raises Lakefront Biotherapeutics Stake Above To 10.11%
Lakefront Biotherapeutics NV ((Euronext &, NASDAQ:LKFT) received a transparency notification from Bank of America.Pursuant to Belgian transparency legislation1, Lakefront received a transparency…
2 months ago globenewswire.com
Lakefront Receives Transparency Notification from Bank of America
Mechelen, Belgium; August 24, 2026, 22.01 CET; regulated information – Lakefront Biotherapeutics NV (Euronext & NASDAQ: LKFT) received a transparency notification from Bank of America.
2 months ago globenewswire.com
U.S. FDA Grants Orphan Drug Designation to Gamgertamig for the Treatment of Pemphigus
Mechelen, Belgium; 24 August 2026, 22.01 CET; regulated information – Lakefront Biotherapeutics NV (Euronext & NASDAQ: LKFT) today announced that the U.S. Food and Drug Administration (FDA) has…
2 months ago globenewswire.com
Acquisition of Own Shares
Mechelen, Belgium; 18 August 2026, 22.01 CET; regulated information Within the framework of the repurchase program announced on June 9, 2026, Lakefront Biotherapeutics NV (Euronext & NASDAQ: LKFT)…
2 months ago globenewswire.com
Acquisition of Own Shares
Mechelen, Belgium; 12 August 2026, 22.01 CET; regulated information Within the framework of the repurchase program announced on June 9, 2026, Lakefront Biotherapeutics NV (Euronext & NASDAQ: LKFT)…
-
2 months ago benzinga.com
Morgan Stanley Maintains Equal-Weight on Lakefront Biotherapeutics, Lowers Price Target to $26
Morgan Stanley analyst Judah Frommer maintains Lakefront Biotherapeutics (NASDAQ:LKFT) with a Equal-Weight and lowers the price target from $30 to $26.
-
2 months ago benzinga.com
RBC Capital Maintains Sector Perform on Lakefront Biotherapeutics, Lowers Price Target to $26
RBC Capital analyst Brian Abrahams maintains Lakefront Biotherapeutics (NASDAQ:LKFT) with a Sector Perform and lowers the price target from $28 to $26.
-
2 months ago benzinga.com
Lakefront Biotherapeutics Q2 EPS $0.29 Beats $(13.52) Estimate, Sales $21.624M Beat $7.210M Estimate
Lakefront Biotherapeutics (NASDAQ:LKFT) reported quarterly earnings of $0.29 per share which beat the analyst consensus estimate of $(13.52) by 102.14 percent. This is a 120 percent increase over…
-
4 months ago benzinga.com
Lakefront Biotherapeutics Receives Transparency Notification As Madison Avenue Partners Crossed Above 5% Of Voting Rights
Lakefront Biotherapeutics NV ((Euronext &, NASDAQ:LKFT) received a transparency notification from Madison Avenue Partners.Pursuant to Belgian transparency legislation1, Lakefront received a…
-
4 months ago benzinga.com
Lakefront Biotherapeutics Repurchases 38,537 Of Its Own Shares Through June 9 - June 12
Lakefront Biotherapeutics NV ((Euronext &, NASDAQ:LKFT) ("Lakefront") announces that it has repurchased 38,537 Lakefront shares between June 9, 2026 and June 12, 2026
-
5 months ago benzinga.com
Lakefront Biotherapeutics Says Bank Of America Raised Its Stake To 9.3% Through Voting Rights And Financial Instruments
Lakefront Biotherapeutics NV ((Euronext &, NASDAQ:LKFT) received a transparency notification from Bank of America.Pursuant to Belgian transparency legislation1, Lakefront received a transparency…